CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple ...

The real-world effectiveness of Monjuvi for relapsed or refractory diffuse large B-cell lymphoma in the U.S. was demonstrated ...

Diffusion component mapping of a robust single-cell RNA sequencing dataset helps to better understand the spatio-temporal dynamics that shape the neural plate of mice during early development. Next, ...

Historically, sickle cell anaemia has been widely neglected within its global epicentre of sub-Saharan Africa. More than ...

Groundbreaking research has uncovered a potential link between a common virus and Alzheimer’s disease, offering fresh ...

Arizona State University and Banner Alzheimer’s Institute researchers, along with their collaborators, have discovered a ...

Arizona State University and Banner Alzheimer's Institute researchers, along with their collaborators, have discovered a surprising link between a chronic gut infection caused by a common virus and ...

The company is using its Senza5 platform to produce CAR T cells without the CD5 receptor, hoping to enable smaller doses and avoid CAR-T fratricide.

Palleon Pharmaceuticals, a company pioneering glyco-immunology drug development to treat autoimmune diseases and cancer, today announced a collaboration and license agreement with Shanghai Henlius ...